Mitsubishi Tanabe Pharma Corp - Strategic SWOT Analysis Review

Mitsubishi Tanabe Pharma Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the companys history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the companys key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description A detailed description of the companys operations and business divisions.
- Corporate strategy summarization of the companys business strategy.
- SWOT analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.
- Company history Progression of key events associated with the company.
- Major products and services A list of major products, services and brands of the company.
- Key competitors A list of key competitors to the company.
- Key employees A list of the key executives of the company.
- Executive biographies A brief summary of the executives employment history.
- Key operational heads A list of personnel heading key departments/functions.
- Important locations and subsidiaries A list of key locations and subsidiaries of the company, including contact details.

Highlights

Mitsubishi Tanabe Pharma Corp (Mitsubishi Tanabe), a subsidiary of Mitsubishi Chemical Holdings Corp, identifies, develops, manufactures, procures and commercializes ethical drugs and over-the-counter (OTC) pharmaceutical products. The company develops ethical drugs for autoimmune disease, diabetes, kidney diseases, central nervous system (CNS) disorders and others. It also develops vaccines for preventing various infectious diseases. The company markets its products to wholesalers, hospitals, clinics, and drugstores. It has subsidiaries in Asia, Europe and North America. Mitsubishi Tanabe is headquartered in Chuo-ku, Osaka, Japan.

Mitsubishi Tanabe Pharma Corp Key Recent Developments

Mar 23,2020: Mitsubishi licences SUDA Pharmaceuticals ZolpiMist in Korea
Nov 15,2019: Mitsubishi Tanabe Pharma America to receive essey commitment to cures award from the ALS Community for extensive efforts and collaboration in ALS research, development and education
Aug 06,2019: Commencement of R&D of Gene Therapy Product for Hemophilia B
Apr 26,2019: BioInvent receives 0.75 million milestone under Mitsubishi Tanabe Pharma partnership
Mar 28,2019: The global health innovative technology fund provides grant for joint research into anti-malarial drugs conducted by Mitsubishi Tanabe Pharma and a malaria research institution

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this reports analysis of the companys business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors business structure and strategies with detailed SWOT analysis. In this, the companys core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this reports detailed insight into the companys strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.




Section 1 - About the Company
Mitsubishi Tanabe Pharma Corp - Key Facts
Mitsubishi Tanabe Pharma Corp - Key Employees
Mitsubishi Tanabe Pharma Corp - Major Products and Services
Mitsubishi Tanabe Pharma Corp - History
Mitsubishi Tanabe Pharma Corp - Company Statement
Mitsubishi Tanabe Pharma Corp - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Section 2 Company Analysis
Company Overview
Mitsubishi Tanabe Pharma Corp - Business Description
Product Category: Domestic Ethical Drugs
Performance
Product Category: OTC Products
Performance
Product Category: Others
Performance
Product Category: Overseas Ethical Drugs
Performance
Product Category: Royalty Revenue, etc.
Performance
Geographical Segment: Domestic
Performance
Geographical Segment: Overseas
Performance
Mitsubishi Tanabe Pharma Corp - SWOT Analysis
SWOT Analysis - Overview
Mitsubishi Tanabe Pharma Corp - Strengths
Mitsubishi Tanabe Pharma Corp - Weaknesses
Mitsubishi Tanabe Pharma Corp - Opportunities
Mitsubishi Tanabe Pharma Corp - Threats
Mitsubishi Tanabe Pharma Corp - Key Competitors
Section 3 Companys Lifesciences Financial Deals and Alliances
Mitsubishi Tanabe Pharma Corp, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Mitsubishi Tanabe Pharma Corp, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Mitsubishi Tanabe Pharma Corp, Recent Deals Summary
Section 4 Companys Recent Developments
Mar 23, 2020: Mitsubishi licences SUDA Pharmaceuticals ZolpiMist in Korea
Nov 15, 2019: Mitsubishi Tanabe Pharma America to receive essey commitment to cures award from the ALS Community for extensive efforts and collaboration in ALS research, development and education
Aug 06, 2019: Commencement of R&D of Gene Therapy Product for Hemophilia B
Apr 26, 2019: BioInvent receives 0.75 million milestone under Mitsubishi Tanabe Pharma partnership
Mar 20, 2019: Mitsubishi Tanabe Pharma: Aiming to expand our sales and to strengthen our business foundations in the growing ASEAN market Establishment of sales subsidiary in Malaysia and Vietnam representative officeAiming to expand our sales and to strengthen our business foundations in the growing ASEAN market Establishment of sales subsidiary in Malaysia and Vietnam representative office
Section 5 Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List Of Tables


Mitsubishi Tanabe Pharma Corp, Key Facts
Mitsubishi Tanabe Pharma Corp, Key Employees
Mitsubishi Tanabe Pharma Corp, Major Products and Services
Mitsubishi Tanabe Pharma Corp, History
Mitsubishi Tanabe Pharma Corp, Other Locations
Mitsubishi Tanabe Pharma Corp, Subsidiaries
Mitsubishi Tanabe Pharma Corp, Joint Venture
Mitsubishi Tanabe Pharma Corp, Key Competitors
Mitsubishi Tanabe Pharma Corp, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Mitsubishi Tanabe Pharma Corp, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Mitsubishi Tanabe Pharma Corp, Recent Deals Summary

List Of Figures


Mitsubishi Tanabe Pharma Corp, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Mitsubishi Tanabe Pharma Corp, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020

Mitsubishi Paper Mills Ltd (3864) - Financial and Strategic SWOT Analysis Review

Mitsubishi Paper Mills Ltd (3864) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled

USD 125 View Report

Top 20 Vaccine Companies In-depth Analysis 2020: Sanofi, Pfizer, GlaxoSmithKline (GSK), Merck & Co., AstraZeneca, Emergent BioSolutions, Mitsubishi Tanabe Pharma, Seqirus (CSL Limited), Other Companies

Top 20 Vaccine Companies In-depth Analysis 2020: Sanofi, Pfizer, GlaxoSmithKline (GSK), Merck & Co., AstraZeneca, Emergent BioSolutions, Mitsubishi Tanabe Pharma, Seqirus (CSL Limited), Other CompaniesThis report presents an in-depth assessment

USD 1390 View Report

Top 20 Vaccine Companies In-depth Analysis 2020: Sanofi, Pfizer, GlaxoSmithKline (GSK), Merck & Co., AstraZeneca, Emergent BioSolutions, Mitsubishi Tanabe Pharma, Seqirus (CSL Limited), Other Companies

Top 20 Vaccine Companies In-depth Analysis 2020: Sanofi, Pfizer, GlaxoSmithKline (GSK), Merck & Co., AstraZeneca, Emergent BioSolutions, Mitsubishi Tanabe Pharma, Seqirus (CSL Limited), Other CompaniesThis report presents an in-depth assessment

USD 1390 View Report

Mitsubishi Tanabe Pharma Corp (4508) - Financial and Strategic SWOT Analysis Review

Mitsubishi Tanabe Pharma Corp (4508) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled

USD 125 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available